Skip to main content
Fr Donate
  1. Home
  2. Research
  3. For researchers
  4. Current funding opportunities
  5. Stand up to cancer canada metastatic breast cancer dream team

Stand up to cancer canada metastatic breast cancer dream team

  1. Home
  2. Research
  3. For researchers
  4. Current funding opportunities
  5. Stand up to cancer canada metastatic breast cancer dream team

Deadline dates

Deadline dates

Letter of Intent due date: August 10, 2018 at 12pm EST

Full application due date: October 26, 2018 at 12pm EST

Anticipated start date: Early 2019

This program is administered by the American Association for Cancer Research International - Canada. Detailed application information can be found on the AACR webpage.

A Webinar is planned to explain the application process and overall objectives of the call. Applicants can register by sending an email at su2ccanada@aacrcanada.ca by July 9th, 2018. Details for the July 16th, 2018 webinar (1-2 EST) will be provided in advance to interested applicants.  

Program description

The Stand Up To Cancer Canada Metastatic Breast Cancer Dream Team, supported by Canadian Cancer Society (CCS) and Canadian Institutes of Health Research (CIHR), represents a new, focused effort to implement advances in metastatic breast cancer research as rapidly as possible through the creation of a collaborative, translational, cancer research "Metastatic Breast Cancer Dream Team". The most talented and promising researchers across Canadian institutions will be assembled into a pan-Canadian Dream Team, forming an optimal configuration of expertise needed to solve key problems in metastatic breast cancer and positively impact patients in the near future. This Metastatic Breast Cancer Dream Team will span multiple disciplines and utilize the new tools of modern biology to attack research questions in a coordinated way. Mechanisms to foster collaborations within the Dream Team will be employed – an approach that promotes the sharing of information and a goal-oriented focus on measurable milestones of progress. SU2C Canada, CCS and CIHR believe that this unique Metastatic Breast Cancer Dream Team model will advance scientific research in the interests of both today's cancer patients and those who may develop cancer in the future.

Total funds up to $6 million CAD are available from the funders; please see the Program Guidelines for further details. This grant offers funding for a 4-year research term, depending upon project requirements, and will be contingent on the SU2C Canada Scientific Advisory Committee (CSAC) and the Canada Metastatic Breast Cancer Subcommittee (CMBCS) finding that the funds are justified and that milestones and deliverables have been appropriately selected and are being satisfactorily pursued and achieved. The funds must be used for research at Canadian institutions.

Eligibility

This research funding opportunity is in support of one integrated and cohesive pan-Canadian Dream Team that will undertake Metastatic Breast Cancer research. The research should focus on critical problems in Metastatic Breast Cancer.

In particular, the applicants must:

  • Focus on addressing critical problems of Metastatic Breast Cancer (see Program Guidelines for details).
  • Present a plan for how the Dream Team's discoveries can be translated into applications with clinical utility.
  • Build a pan-Canadian program (includes Dream Team Leader, Co-leader and Principals from AT LEAST 3 different regions) which brings together interdisciplinary research groups to answer questions that will significantly advance the field of Metastatic Breast Cancer Research.
  • Display integration, cohesion, and leveraged networking with respect to resource and data sharing mechanisms for existing and planned platforms, resources, and results.
  • Present innovative approaches and integrate advances from other fields or technologies.
  • Include training opportunities for the future generation of scientists and foster an entrepreneurial culture within the community.
  • Address issues of importance to end-users, including patients, industry, health care administrators and oncology practice guideline panels.
  • Each Team will consist of a Dream Team Leader, a Dream Team Co-leader, no more than four additional Dream Team Principals, at least 2 Early Career Investigators, a Dream Team Project Manager, and at least two Advocates, with no more than six but a minimum of three participating institutions. Leader, Co-leader, and Principals must each be from a unique institution across 3 different regions of Canada.

For the full Dream Team Composition criteria, please refer to the full Program Guideline (PDF). Candidates with a question about the eligibility requirements are encouraged to contact AACR International-Canada at su2ccanada@aacrcanada.ca  prior to submitting the proposal.

Citizenship Requirements: No requirement.

AACR Membership Requirements: No requirement.

Application Instructions

The AACR International-Canada requires applicants to submit their Letter of Intent (LOI) via proposalCENTRAL by 12:00 p.m. (noon), Eastern Time on Friday, August 10, 2018 using the proposalCENTRAL website at https://proposalcentral.altum.com

Invited Full Proposals for the Stand Up To Cancer Canada Metastatic Breast Cancer Dream Team must be submitted by 12:00 pm Eastern Time on Friday, October 26, 2018 using the proposalCENTRAL website.

The LOI and the Full application must be submitted in English.

Last modified on: March 6, 2020